CHSYF (China Medical System Holdings) Total Stockholders Equity: $2,649 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHSYF China Medical System Holdings Ltd CHSYF
87 GF Score
Price $1.57
GF Value $1.79
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is China Medical System Holdings Total Stockholders Equity?

China Medical System Holdings CHSYF +0.11% 87 Total Stockholders Equity is $2,649 Mil as of Jun. 2026. GuruFocus rates CHSYF with a GF Score™ of 87/100 and a GF Value™ of $1.79 (Modestly Undervalued). The stock has 3 warning signs investors should review.

China Medical System Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $2,649 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. China Medical System Holdings's Book Value per Share for the quarter that ended in Jun. 2026 was $1.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. China Medical System Holdings's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.05.


China Medical System Holdings  (OTCPK:CHSYF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

China Medical System Holdings's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

China Medical System Holdings's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings Total Stockholders Equity Related Terms


China Medical System Holdings Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for China Medical System Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Medical System Holdings Total Stockholders Equity Chart

China Medical System Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,002.17 2,092.61 2,173.64 2,240.37 2,469.86

China Medical System Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,193.94 2,240.37 2,370.20 2,469.86 2,648.68
CHSYF
87GF Score
China Medical System Holdings Ltd CHSYF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $2,649 Mil mean?
China Medical System Holdings (CHSYF) has a Total Stockholders Equity of $2,649 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for China Medical System Holdings and its competitors.
Is China Medical System Holdings' Total Stockholders Equity too high?
China Medical System Holdings' current Total Stockholders Equity is $2,649 Mil. Overall, China Medical System Holdings has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' Total Stockholders Equity compare to ZTS?
China Medical System Holdings' Total Stockholders Equity of $2,649 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for China Medical System Holdings and its competitors. China Medical System Holdings's current Total Stockholders Equity is $2,649 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (CHSYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.79, compared to a current price of $1.57 — trading 12.3% below its estimated fair value. The current Total Stockholders Equity is $2,649 Mil. China Medical System Holdings' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For China Medical System Holdings (CHSYF), the current Total Stockholders Equity is $2,649 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Medical System Holdings (CHSYF) Overvalued in 2026?

Based on GuruFocus' analysis, China Medical System Holdings stock appears to be undervalued. The current stock price of $1.57 is trading 12.3% below its estimated GF Value™ of $1.79. GuruFocus considers China Medical System Holdings to be Modestly Undervalued.

Key valuation signals for CHSYF:

  • Total Stockholders Equity: $2,649 Mil
  • GF Value™: $1.79 vs. price of $1.57 (12.3% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the CHSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Medical System Holdings Business Description

Address 510 King’s Road, Unit 2106, 21st Floor, Island Place Tower, North Point, Hong Kong, HKG
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
87GF Score

Get the complete analysis for CHSYF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.57
Price
$1.79
GF Value